Top Markets
Coin of the day
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
Kedudukan dalam Saham #3183
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Harga Saham
$9.97
Disegerakkan terakhir: 2026-08-25
Modal Pasaran
$5.96B
Perubahan (1 hari)
5.06%
Perubahan (1 tahun)
0.53%
Negara
CN
Perdagangan Gan & Lee Pharmaceuticals. (603087)

Kategori

Sejarah harga saham bagi Gan & Lee Pharmaceuticals. (603087)
Harga penutupan tertinggi: $10.41 pada 2026-08-01

Harga penutupan terendah: $9.67 pada 2020-06-01
Sejarah harga saham Gan & Lee Pharmaceuticals. dari 2020 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 0.59%
2025 49.04%
2024 -17.59%
2023 56.66%
2022 -56.78%
2021 -39.34%
2020 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$371.13 -21.75%
US
$188.78 -39.02%
FR
$160.53 22.90%
JP
$189.94 24.49%
US
$76.37 -5.96%
CH